UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of July 2023
Commission File Number: 001-39810
IDEX Biometrics ASA
(Translation of registrant’s name into English)
Dronning Eufemias gate 16
Oslo, Norway
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐ Form 40-F
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Other
On July 21, 2023, IDEX Biometrics ASA (the “Company”) issued a press release announcing its intention to voluntarily delist its American Depositary Shares from The Nasdaq Capital Market. A copy of this press release is attached to this Report on Form 6-K as Exhibit 99.1 and is hereby incorporated by reference.
EXHIBIT LIST
Exhibit |
|
Description |
|
|
|
99.1 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
IDEX BIOMETRICS ASA |
||
|
|
|
|
|||
Date: July 21, 2023 |
|
|
|
By: |
|
/s/ Vincent Graziani |
|
|
|
|
|
|
Name: Vincent Graziani |
|
|
|
|
|
|
Title: Chief Executive Officer |